Burning Rock Biotech Ltd — Investor Relations & Filings
Filings indexed
162
across all filing types
Latest filing
2026-04-28
Annual Report
Country
US
United States of America
Listing
US
BNR
Burning Rock Biotech Ltd. is a global diagnostics company specializing in precision oncology. The company focuses on applying next-generation sequencing (NGS) technology to develop and commercialize solutions for cancer diagnostics. Its portfolio includes NGS-based assays for both tissue and liquid biopsies, designed for cancer therapy selection and early detection. Burning Rock offers solutions covering the entire precision oncology development cycle, supported by an in-house database to facilitate clinical trials and research.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 20-F - Burning Rock Biotech Ltd (0001792267) (Filer) | 2026-04-28 | English | |
| 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-19 | English | |
| 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | |
| 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | |
| 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | |
| 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 37943682 | 20-F - Burning Rock Biotech Ltd (0001792267) (Filer) | 2026-04-28 | English | ||
| 32981146 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-19 | English | ||
| 32964898 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | ||
| 32964752 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | ||
| 32964743 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | ||
| 32964729 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | ||
| 32964721 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | ||
|
2025
8 filings
| |||||
| 13213432 | FORM 6-K | 2025-12-23 | English | ||
| 13213433 | Major Shareholding Notification 2025 | 2025-12-19 | English | ||
| 13213434 | FORM 6-K | 2025-12-01 | English | ||
| 13213435 | FORM 6-K | 2025-11-20 | English | ||
| 13213436 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13213437 | FORM 6-K | 2025-09-08 | English | ||
| 13213438 | FORM 6-K | 2025-06-06 | English | ||
| 13213439 | FORM 20-F | 2025-04-29 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
IMCB PJSC
Biotechnology company specializing in personal stem cell ba…
|
GEMA | RU | Professional, scientific and te… |
|
Immuneering Corp
Clinical-stage oncology company developing medicines using …
|
IMRX | US | Professional, scientific and te… |
|
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Clinical-stage biotech developing dual-approach immuno-onco…
|
1541 | HK | Professional, scientific and te… |
|
IMMUNIC, INC.
Develops oral small molecule therapies for chronic inflamma…
|
IMUX | US | Professional, scientific and te… |
|
Immunovant, Inc.
Clinical-stage immunology company developing anti-FcRn anti…
|
IMVT | US | Professional, scientific and te… |
|
IMMUPHARMA PLC
Specialty biopharmaceutical company developing peptide-base…
|
IMM | GB | Professional, scientific and te… |
|
IMMUTEP LIMITED
Develops LAG-3 targeting immunotherapies for cancer and aut…
|
IMM | AU | Professional, scientific and te… |
|
IMMUTEP Ltd
Biotechnology company developing LAG-3 immunotherapies for …
|
IMMP | US | Professional, scientific and te… |
|
IMPACT BIOMEDICAL INC.
Develops biopharmaceutical products and technologies to pro…
|
IBO | US | Professional, scientific and te… |
|
IMUGENE LIMITED
Clinical-stage immuno-oncology company developing cancer im…
|
IMU | AU | Professional, scientific and te… |
Burning Rock Biotech Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34185/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34185 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34185 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34185 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34185}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Burning Rock Biotech Ltd (id: 34185)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.